nejm semaglutide ckd Updates in Medicine | 🩺 Oral Cuts CV Risk in High-Risk T2DM – SOUL Trial (NEJM, Mar 2025) 🔗 Original article link in bio 📌 Key Highlights: 🔹 Semaglutide, Chronic Kidney Disease, and

While glucagon-like peptide-1 receptor modulators (GLP-1 RMs) are established therapies for obesity, their role in the management of dumping syndrome remains unclear

These combined actions underscore their therapeutic potential for NAFLD (89, 90)

These shifts affect many systems including hormones, metabolism, bone health, and cardiovascular function

This condition, known as diabetic ketoacidosis, can lead to hazardous complications that are harmful to the patient's health and may even be life-threatening (101)

doi: 10.3389/fimmu.2025.1547888

Support groups can be a very personal experience when you can make some much-needed connections with fellow members of the OCD community